Arbutus Biopharma Appoints Andrew Cheng, M.D., Ph.D., to its Board of Directors

    NEXT STORY
    CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019
    PREV STORY
    Air Methods Celebrates ARCH Air Medical’s 40th Year of Dedication to the St. Louis Area
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Spring Bank Submits IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors

    author_avatar
    NASDAQ Market News

    Global Nephrology And Urology Devices Industry

    author_avatar
    NASDAQ Market News

    Ziopharm Oncology to Host Conference Call to Discuss Second Quarter 2019 Results on August 8, 2019

    author_avatar
    NASDAQ Market News